REGENXBIO Inc. (RGNX)

REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	57.77	34.52	96.95	345.21	338.43	69.51
Short-Term Investments	232.59	240.74	267.69	112.23	137.31	226.7
Cash & Short-Term Investments	290.36	275.26	364.64	457.44	475.74	296.21
Cash Growth	-9.29%	-24.51%	-20.29%	-3.85%	60.61%	-7.37%
Accounts Receivable	22.81	24.79	28.08	28.51	43.35	38.15
Other Receivables	22.31	19.3	8.5	-	-	-
Receivables	45.12	44.09	36.59	28.51	43.35	38.15
Prepaid Expenses	10.02	14.52	13.9	18.75	10.51	6.48
Other Current Assets	1.19	1.11	0.85	14.12	1.6	4.2
Total Current Assets	346.68	334.97	415.98	518.83	531.2	345.03
Property, Plant & Equipment	180.31	192.59	206.8	192.45	120.28	39.05
Long-Term Investments	36.94	38.87	200.56	391.91	47.91	103.79
Long-Term Accounts Receivable	0.46	0.7	1.5	2.26	3.27	4.16
Other Long-Term Assets	4.98	6.84	8.43	8.46	5.51	5.89
Total Assets	569.38	573.97	833.27	1,114	708.16	497.91
Accounts Payable	16.36	22.79	27.21	11.39	10.62	6.41
Accrued Expenses	42.35	49.32	45.99	59.5	38.09	23.52
Current Portion of Long-Term Debt	32.1	50.57	48.6	37.89	18.79	-
Current Portion of Leases	7.3	7.07	6	1.75	2.5	2.42
Current Income Taxes Payable	-	-	-	11.33	3.14	-
Current Unearned Revenue	0.02	0.15	1.83	3.33	0.45	-
Other Current Liabilities	0.14	0.39	0.81	5.29	7.85	1.33
Total Current Liabilities	98.27	130.27	130.43	130.47	81.45	33.68
Long-Term Debt	41.08	43.49	89.01	133.46	174.5	-
Long-Term Leases	78.23	82.22	88.8	84.93	70.15	8.87
Long-Term Unearned Revenue	-	-	-	-	3.78	3.33
Other Long-Term Liabilities	3.53	6.25	8.83	0.75	0.52	1.83
Total Liabilities	221.11	262.23	317.07	349.61	330.41	47.71
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	1,172	1,021	973.15	928.1	667.18	627.81
Retained Earnings	-821.37	-705.05	-441.55	-161.23	-289.07	-177.82
Comprehensive Income & Other	-2.27	-4.43	-15.4	-2.57	-0.36	0.21
Total Common Equity	348.27	311.74	516.2	764.3	377.75	450.2
Shareholders' Equity	348.27	311.74	516.2	764.3	377.75	450.2
Total Liabilities & Equity	569.38	573.97	833.27	1,114	708.16	497.91
Total Debt	158.72	183.34	232.41	258.03	265.95	11.3
Net Cash (Debt)	168.59	130.79	332.8	591.32	256.6	388.7
Net Cash Growth	-18.74%	-60.70%	-43.72%	130.44%	-33.99%	-16.36%
Net Cash Per Share	3.66	2.99	7.71	13.47	6.88	10.59
Filing Date Shares Outstanding	49.42	44.43	43.46	42.95	42.5	37.14
Total Common Shares Outstanding	49.32	44.05	43.3	42.83	37.48	36.99
Working Capital	248.41	204.7	285.54	388.35	449.75	311.36
Book Value Per Share	7.06	7.08	11.92	17.84	10.08	12.17
Tangible Book Value	348.27	311.74	516.2	764.3	377.75	450.2
Tangible Book Value Per Share	7.06	7.08	11.92	17.84	10.08	12.17
Machinery	88.03	87.38	83.68	68.05	34.18	24.4
Leasehold Improvements	101.34	101.93	99.4	92.54	44.96	18.92

Source: S&P Capital IQ. Standard template. Financial Sources.